Although inflammation is a suggested feature of non-alcoholic fatty liver disease (NAFLD), data on circulating levels of interleukins in NAFLD are rather scarce, but increased levels of IL-6 and IL-8 [24], [25], but not IL-18 [26], have been reported in individuals with NAFDL. Here, IL18 is linked to metabolic dysfunction-associated steatotic liver disease.